Skip to content

“Mini-mental state”

Why this mattered

Folstein, Folstein, and McHugh’s 1975 paper mattered because it turned bedside cognitive assessment into a brief, reproducible instrument. Before the Mini-Mental State Examination, clinicians could describe confusion, dementia, or organic brain syndrome, but comparisons across patients, raters, wards, and studies were often loose and impressionistic. The paper’s central shift was methodological: cognition could be sampled in a few minutes through a standardized 30-point test covering orientation, registration, attention and calculation, recall, language, and simple construction, while deliberately separating cognitive performance from mood, psychosis, or personality symptoms.

That made new kinds of clinical and research work possible. The MMSE gave psychiatry, neurology, geriatrics, and primary care a common quantitative language for cognitive impairment, enabling screening, longitudinal follow-up, treatment monitoring, epidemiologic surveys, and trial eligibility criteria at scale. Its simplicity was part of its power: it could be used outside specialist neuropsychology, making cognitive measurement portable across hospitals, clinics, nursing homes, and population studies.

Its limitations later became equally important. The MMSE is affected by education, language, culture, sensory impairment, and ceiling effects, and it is relatively insensitive to some executive and mild cognitive deficits. But those criticisms helped define the next generation of cognitive instruments, including more domain-sensitive dementia screens and trial batteries. In that sense, the paper did not merely introduce a test; it established brief standardized cognitive screening as a clinical infrastructure, shaping how Alzheimer’s disease, delirium, vascular cognitive impairment, and later biomarker-era dementia research were detected, staged, and measured.

Abstract

(no abstract available)

Sources